-
Je něco špatně v tomto záznamu ?
The impact of expiratory muscle strength training on voluntary cough effectiveness in Huntington's disease
R. Konvalinkova, M. Srp, K. Doleckova, V. Capek, O. Gal, M. Hoskovcova, R. Kliment, J. Muzik, E. Ruzicka, J. Klempir
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
Grantová podpora
MH CZ - DRO - VFN00064165
Všeobecná Fakultní Nemocnice v Praze
NLK
PubMed Central
od 2024
ProQuest Central
od 2024-01-01
Health & Medicine (ProQuest)
od 2024-01-01
Wiley-Blackwell Open Access Titles
od 2024
PubMed
39344651
DOI
10.1111/ene.16500
Knihovny.cz E-zdroje
- MeSH
- dechová cvičení metody MeSH
- dospělí MeSH
- dýchací svaly * patofyziologie MeSH
- Huntingtonova nemoc * patofyziologie komplikace rehabilitace MeSH
- kašel * patofyziologie etiologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- odporový trénink metody MeSH
- prospektivní studie MeSH
- studie případů a kontrol MeSH
- svalová síla * fyziologie MeSH
- výsledek terapie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND AND PURPOSE: Dysfunction of the airway defence system in Huntington's disease (HD) is a significant but often overlooked problem. Although expiratory muscle strength training (EMST) is frequently utilized in cough effectiveness treatment, its specific impact in HD patients has not yet been explored. This study investigated the effects of EMST on voluntary peak cough flow (vPCF) in HD patients and evaluated the retention of potential gains post-intervention. METHODS: In this prospective case-controlled trial, 29 HD patients completed an 8-week wait-to-start period, which served to identify the natural development of expiratory muscle strength and vPCF. This was followed by 8 weeks of EMST training and an additional 8 weeks of follow-up. The study's outcome parameters, vPCF and maximum expiratory pressure (MEP), were measured against those of age- and sex-matched healthy controls. RESULTS: Huntington's disease patients had significantly lower MEP (p < 0.001) and vPCF (p = 0.012) compared to healthy controls at baseline. Following the EMST, significant improvements in MEP (d = 1.39, p < 0.001) and vPCF (d = 0.77, p = 0.001) were observed, with HD patients reaching the cough performance levels of healthy subjects. However, these gains diminished during the follow-up, with a significant decline in vPCF (d = -0.451, p = 0.03) and in MEP (d = -0.71; p = 0.002). CONCLUSIONS: Expiratory muscle strength training improves expiratory muscle strength and voluntary cough effectiveness in HD patients, but an ongoing maintenance programme is necessary to sustain the improvements.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25003241
- 003
- CZ-PrNML
- 005
- 20250206104206.0
- 007
- ta
- 008
- 250121s2024 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/ene.16500 $2 doi
- 035 __
- $a (PubMed)39344651
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Konvalinkova, Romana $u Department of Neurology and Centre of Clinical Neuroscience, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
- 245 14
- $a The impact of expiratory muscle strength training on voluntary cough effectiveness in Huntington's disease / $c R. Konvalinkova, M. Srp, K. Doleckova, V. Capek, O. Gal, M. Hoskovcova, R. Kliment, J. Muzik, E. Ruzicka, J. Klempir
- 520 9_
- $a BACKGROUND AND PURPOSE: Dysfunction of the airway defence system in Huntington's disease (HD) is a significant but often overlooked problem. Although expiratory muscle strength training (EMST) is frequently utilized in cough effectiveness treatment, its specific impact in HD patients has not yet been explored. This study investigated the effects of EMST on voluntary peak cough flow (vPCF) in HD patients and evaluated the retention of potential gains post-intervention. METHODS: In this prospective case-controlled trial, 29 HD patients completed an 8-week wait-to-start period, which served to identify the natural development of expiratory muscle strength and vPCF. This was followed by 8 weeks of EMST training and an additional 8 weeks of follow-up. The study's outcome parameters, vPCF and maximum expiratory pressure (MEP), were measured against those of age- and sex-matched healthy controls. RESULTS: Huntington's disease patients had significantly lower MEP (p < 0.001) and vPCF (p = 0.012) compared to healthy controls at baseline. Following the EMST, significant improvements in MEP (d = 1.39, p < 0.001) and vPCF (d = 0.77, p = 0.001) were observed, with HD patients reaching the cough performance levels of healthy subjects. However, these gains diminished during the follow-up, with a significant decline in vPCF (d = -0.451, p = 0.03) and in MEP (d = -0.71; p = 0.002). CONCLUSIONS: Expiratory muscle strength training improves expiratory muscle strength and voluntary cough effectiveness in HD patients, but an ongoing maintenance programme is necessary to sustain the improvements.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a Huntingtonova nemoc $x patofyziologie $x komplikace $x rehabilitace $7 D006816
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a dospělí $7 D000328
- 650 12
- $a kašel $x patofyziologie $x etiologie $7 D003371
- 650 12
- $a svalová síla $x fyziologie $7 D053580
- 650 12
- $a dýchací svaly $x patofyziologie $7 D012132
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a dechová cvičení $x metody $7 D001945
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a odporový trénink $x metody $7 D055070
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Srp, Martin $u Department of Neurology and Centre of Clinical Neuroscience, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000322150272
- 700 1_
- $a Doleckova, Kristyna $u Department of Neurology and Centre of Clinical Neuroscience, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Capek, Vaclav $u Department of Neurology and Centre of Clinical Neuroscience, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Gal, Ota $u Department of Neurology and Centre of Clinical Neuroscience, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Hoskovcova, Martina $u Department of Neurology and Centre of Clinical Neuroscience, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Kliment, Radim $u Faculty of Biomedical Engineering, Czech Technical University, Prague, Czech Republic
- 700 1_
- $a Muzik, Jan $u Faculty of Biomedical Engineering, Czech Technical University, Prague, Czech Republic
- 700 1_
- $a Ruzicka, Evzen $u Department of Neurology and Centre of Clinical Neuroscience, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Klempir, Jiri $u Department of Neurology and Centre of Clinical Neuroscience, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
- 773 0_
- $w MED00001629 $t European journal of neurology $x 1468-1331 $g Roč. 31, č. 12 (2024), s. e16500
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39344651 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250121 $b ABA008
- 991 __
- $a 20250206104201 $b ABA008
- 999 __
- $a ok $b bmc $g 2263159 $s 1239248
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 31 $c 12 $d e16500 $e 20240930 $i 1468-1331 $m European journal of neurology $n Eur J Neurol $x MED00001629
- GRA __
- $a MH CZ - DRO - VFN00064165 $p Všeobecná Fakultní Nemocnice v Praze
- LZP __
- $a Pubmed-20250121